TANG CAPITAL MANAGEMENT LLC Diversified Active

Location: San Diego, CA

CIK: 0001232621 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value: $224M (89.4% shares, 10.6% debt)

Holdings (12)

HRTX HERON THERAPEUTICS INC 49.8%
Value $112M Shares 6,197,198 Share Price $18.05 * Est. Cost/Share $13.95 Unrealized @ Report Date +40.0%
— LA JOLLA PHARMACEUTICAL CO 21.8%
Value $48.83M Shares 3,052,130 Share Price $16.00 Est. Cost/Share $14.80 Unrealized @ Report Date —
— IGNYTA INC 9.6%
Value $21.53M Shares 3,972,800 Share Price $5.42 Est. Cost/Share $5.43 Unrealized @ Report Date —
— OPKO HEALTH INC 8.8%
Value $19.75M Shares 14,000,000 Share Price $1.41 Est. Cost/Share $1.47 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 3.1%
Value $7.019M Shares 90,215 Share Price $77.80 * Est. Cost/Share $62.32 Unrealized @ Report Date +36.4%
BABA ALIBABA GROUP HOLDING LIMITED 2.1%
Value $4.772M Shares 60,000 Share Price $79.53 Est. Cost/Share $79.03 Unrealized @ Report Date —
— MERRIMACK PHARMACEUTICALS INC 1.8%
Value $3.965M Shares 3,500,000 Share Price $1.13 Est. Cost/Share $1.36 Unrealized @ Report Date —
— NEKTAR THERAPEUTICS 1.6%
Value $3.7M Shares 260,000 Share Price $14.23 Est. Cost/Share $13.75 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS INC 0.5%
Value $1.221M Shares 430,000 Share Price $2.84 * Est. Cost/Share $4.43 Unrealized @ Report Date -29.9%
— LIPOCINE INC 0.4%
Value $790K Shares 260,000 Share Price $3.04 Est. Cost/Share $5.77 Unrealized @ Report Date —
— ATYR PHARMA INC 0.3%
Value $777K Shares 279,425 Share Price $2.78 Est. Cost/Share $3.57 Unrealized @ Report Date —
— CELLDEX THERAPUETICS INC 0.1%
Value $220K Shares 50,000 Share Price $4.40 Est. Cost/Share $3.78 Unrealized @ Report Date —